MiRxes
MiRxes, PT Elion to Develop Cancer Tests for Indonesian Population
As part of the arrangement, PT Elion will validate MiRxes' microRNA-based tests for stomach and lung cancer in an Indonesian cohort.
MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.
MiRxes, Singapore Healthcare Organizations Partner to Develop Multi-Cancer Early Detection Test
Under a memorandum of understanding, the partners will share IP rights and any resulting testing kits will be developed, manufactured, and commercialized by MiRxes.
MiRxes, BGI Research, MGI Partner on Spatial Genomics in Singapore
The three-way strategic partnership aims to develop a spatial multiomics pipeline to foster further regional collaborations.
The firm said it has long-term plans to launch multiple miRNA screening tests for cancers that would run in labs or at the point of care using one blood sample.